- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 309/02 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 309/02
Total number of patents in this class: 64
10-year publication summary
4
|
0
|
0
|
3
|
3
|
4
|
2
|
5
|
3
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The University of British Columbia | 1495 |
3 |
Boehringer Ingelheim International GmbH | 4642 |
2 |
President and Fellows of Harvard College | 5986 |
2 |
Eli Lilly and Company | 3848 |
2 |
JNC Corporation | 1561 |
2 |
JNC Petrochemical Corporation | 399 |
2 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 829 |
2 |
Virent, Inc. | 125 |
2 |
Wuhan Institute of Virology, Chinese Academy of Sciences | 48 |
2 |
Lilly China Research and Development Co., Ltd. | 41 |
2 |
Beijing Increase Innovative Drug Co., Ltd | 8 |
2 |
International Business Machines Corporation | 61305 |
1 |
Merck Sharp & Dohme Corp. | 2191 |
1 |
Merck Patent GmbH | 5815 |
1 |
Centre National de La Recherche Scientifique | 10464 |
1 |
Toray Industries, Inc. | 6950 |
1 |
Agency for Science, Technology and Research | 3628 |
1 |
Boyce Thompson Institute for Plant Research, Inc. | 31 |
1 |
Callaghan Innovation Research Limited | 7 |
1 |
Dainippon Sumitomo Pharma Co., Ltd. | 194 |
1 |
Other owners | 32 |